Ginkgo Bioworks Holdings, Inc. (DNA)

USD 8.79

(-8.53%)

Operating Expenses Summary of Ginkgo Bioworks Holdings, Inc.

  • Ginkgo Bioworks Holdings, Inc.'s latest annual operating expenses in 2023 was 1.1 Billion USD , down -67.17% from previous year.
  • Ginkgo Bioworks Holdings, Inc.'s latest quarterly operating expenses in 2024 Q1 was 174.61 Million USD , up 0.78% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported a annual operating expenses of 2.48 Billion USD in annual operating expenses 2022, up 23.34% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported a annual operating expenses of 2.01 Billion USD in annual operating expenses 2021, up 916.1% from previous year.
  • Ginkgo Bioworks Holdings, Inc. reported a quarterly operating expenses of 175.68 Million USD for 2024 Q2, up 53.11% from previous quarter.
  • Ginkgo Bioworks Holdings, Inc. reported a quarterly operating expenses of 238.69 Million USD for 2023 Q3, down -3.22% from previous quarter.

Annual Operating Expenses Chart of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Historical Annual Operating Expenses of Ginkgo Bioworks Holdings, Inc. (2023 - 2001)

Year Operating Expenses Operating Expenses Growth
2023 1.1 Billion USD -67.17%
2022 2.48 Billion USD 23.34%
2021 2.01 Billion USD 916.1%
2020 198.07 Million USD 57.47%
2019 125.78 Million USD 0.0%
2001 177.86 Million USD 0.0%

Peer Operating Expenses Comparison of Ginkgo Bioworks Holdings, Inc.

Name Operating Expenses Operating Expenses Difference
ADC Therapeutics SA 233.01 Million USD -375.669%
Alto Neuroscience, Inc. 37.8 Million USD -2831.524%
Annovis Bio, Inc. 45.03 Million USD -2361.152%
Biohaven Pharmaceutical Holding Company Ltd. 436.05 Million USD -154.186%
Nuvation Bio Inc. 99.82 Million USD -1010.356%
Nuvation Bio Inc. 99.82 Million USD -1010.356%
Arcus Biosciences, Inc. 457 Million USD -142.534%
Theriva Biologics, Inc. 21.43 Million USD -5071.854%
Zymeworks Inc. 196.76 Million USD -463.316%